Ovarian cancer | Page 3 of 11

Gene :: Researchers identify genetic mutation that may alter tumor cell proliferation

Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. The altered form of AKT1 appears to cause tumor cell proliferation and may play a role in making cells resistant to certain types of therapies. The findings are reported in an advance online publication (AOP) of the journal Nature.

Endometriosis :: New approaches to endometriosis treatment – mouse experiments point the way

Possible new directions for the treatment of endometriosis, a painful condition associated with infertility that affects up to 15 percent of women of reproductive age, will be outlined in the presentation of two experimental studies at the 23rd annual conference of the European Society of Human Reproduction and Embryology.

Endometriosis :: Endometriosis increases the risk of certain cancers

Doctors in Sweden have shown for the first time that although endometriosis is associated with an increased risk of various cancers, this risk does not depend on the number of times women with the condition have given birth.

Genome :: Cancer Genome Atlas awards funds for technology development

As part of The Cancer Genome Atlas (TCGA) pilot project, the National Institutes of Health (NIH) today awarded eight two-year grants totaling $3.4 million to support the development of innovative technologies for exploring the genomic underpinnings of cancer.

MRI :: MRI plus X-ray mammography doubles breast cancer detection in women at high risk

For women at high risk of breast cancer, use of magnetic resonance imaging (MRI) plus X-ray mammography for screening will detect more breast cancers than mammography alone, a new technology assessment has found.

Fertility :: Survivors of rare ovarian cancer retain fertility, have positive relationships

Ovarian germ cell tumor patients treated with platinum-based chemotherapy and fertility-sparing surgery are likely to retain their menstrual function and reproductive ability, according to the largest and most comprehensive survey of survivors ever conducted.

Cancer :: New genetic marker characterizes aggressiveness of cancer cells

Levels of a small non-coding RNA molecule called let-7 appear to define different stages of cancer better than some of the “classical” markers for tumor progression, researchers from the University of Chicago report in the June 25, 2007, early online edition of the Proceedings of the National Academy of Sciences.

Breast Cancer :: Family structure size could affect breast cancer risk prediction accuracy for BRCA gene testing

Researchers have found that the probability of the breast cancer gene mutation BRCA among women with a history of breast cancer is greater when the number of older, female relatives in the family is smaller, according to a study in the June 20 issue of JAMA.

Ovarian Cancer :: Ovarian cancer groups support consensus on ovarian cancer symptoms

Statement on the Ovarian Cancer Symptoms Consensus issued from the Ovarian & Gynecologic Cancer Coalition/Rhonda’s Club and In My Sister’s Care:

Ovarian Cancer :: Hormone therapy can extend life in ovarian cancer patients

The targeted use of an anti-estrogen drug could prolong the life of some ovarian cancer patients by up to three years, and delay the use of chemotherapy in others, revealed by researchers at the University of Edinburgh.